|
|
|
|
|
Treatment Holds Death at Bay
By David Brown Some miracles come in time, and some miracles teach people about time itself. Karen Lyons can testify to the first kind of miracle. Two years ago, she was seriously ill with AIDS, barely able to get out of bed, ready for the funeral she had already planned. Today, the 36-year-old Philadelphia woman rides a bike. She has become a foster mother to a small child. She's making plans to go to graduate school in January. Jerry Roemer is perhaps a testament to the second kind of miracle. A young Washington lawyer, he was even closer to death last year. Through courage and medicine, he traced a path partway back to health and work, to pleasures and responsibilities he had given up, before AIDS finally overtook him last month at the age of 32. The source of both miracles is the new use of three antiviral drugs as therapy for human immunodeficiency virus (HIV) infection. It's a strategy of treatment that, for the first time, is allowing some people to think of HIV infection as a disease they may live with until they are old. About 200,000 people perhaps one-quarter of the people in the United States infected with HIV are now on"triple therapy," as the various combinations of drugs are collectively termed. Most have started in just the last 12 months. For some people this long-awaited therapeutic breakthrough has come too late to make much difference. Triple therapy has offered a fleeting even a cruel glimpse of health before returning them to AIDS's familiar downward course to death. But for others with the advanced stage of HIV infection called AIDS, the new treatments have restored pasts that had been abandoned and helped birth futures that weren't thought to exist. When Lyons tested positive for HIV in late 1989, she so thoroughly resigned herself to dying young that when she found herself alive two years later, she was quite surprised. So surprised, in fact, that she decided to quit drugs, quit alcohol and try to restore order to her life.
© 1997 The Washington Post Company
|
|
|
|
[an error occurred while processing this directive] |